 |
 |
| Cell therapy enabling safe haploidentical haematopoietic stem cell transplantation (HSCT) for the treatment of haematological malignancies. Phase III in high-risk acute leukaemia started in Italy |
 |
|
 |
 |
| A novel VTA for vascularised solid tumours. Phase II trials as single agent ongoing in colorectal and liver cancer, and in mesothelioma. Phase II trials in combination ongoin with Xelox in colorectal cancer, and with doxorubicin in small-cell lung and ovarian cancer |
 |
|
|
|
|
